Wayne State University School of Medicine, Detroit, MI, USA.
Children's Hospital of Michigan, Detroit, MI, USA.
J Clin Immunol. 2020 Nov;40(8):1111-1115. doi: 10.1007/s10875-020-00850-2. Epub 2020 Aug 29.
Stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI) is a rare disorder that is associated with extensive inflammation throughout the body due to a high interferon state. Common clinical manifestations of this disorder include chronic lung disease, digital necrosis, recurrent low-grade fevers, and inflammatory skin lesions. However, renal involvement in patients with SAVI has been sparsely documented. We describe a unique case of pediatric SAVI associated with thrombotic microangiopathy (TMA), collapsing focal segmental glomerulosclerosis, interstitial lung disease (from SAVI involvement), and chronic kidney disease. This patient had a substantial hospital course where he developed renal failure. Extensive studies were conducted to exclude all other causes, including infection and possible drug side effects. Ultimately, immunologic evaluation demonstrated normal complement studies, a low ADAMTS13, and presence of ADAMTS13 inhibitor. There was also evidence of thrombocytopenia and schistocytes on peripheral blood smear. Subsequently, the patient was diagnosed with TMA and he was treated with fresh frozen plasma. Repeat immunologic studies confirmed that the TMA had resolved. In addition to describing a novel association between TMA and SAVI, this case also illustrates the challenges associated with optimizing treatment regimens and the importance of clinical vigilance for atypical complications that may arise in patients with SAVI.
干扰素基因刺激物(STING)相关的婴儿期起病血管病(SAVI)是一种罕见疾病,由于干扰素状态高,全身广泛炎症。这种疾病的常见临床表现包括慢性肺部疾病、指(趾)坏死、复发性低度发热和炎症性皮肤损伤。然而,SAVI 患者的肾脏受累鲜有报道。我们描述了一例独特的儿科 SAVI 病例,该病例伴有血栓性微血管病(TMA)、局灶性节段性肾小球硬化症(FSGS)、间质性肺病(由 SAVI 引起)和慢性肾脏病。该患者的住院过程较为复杂,他发展为肾衰竭。进行了广泛的研究以排除所有其他原因,包括感染和可能的药物副作用。最终,免疫评估显示补体研究正常,ADAMTS13 水平低,存在 ADAMTS13 抑制剂。外周血涂片也有血小板减少和裂体细胞的证据。随后,该患者被诊断为 TMA,并接受了新鲜冷冻血浆治疗。重复的免疫研究证实 TMA 已经得到缓解。除了描述 TMA 与 SAVI 之间的新关联外,该病例还说明了优化治疗方案所面临的挑战,以及对 SAVI 患者可能出现的非典型并发症保持临床警惕的重要性。